Carcinoma, Acinar Cell - 25 Studies Found
Active, not recruiting |
: Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer :
|
Recruiting |
: Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer :
|
Completed |
: CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer :
|
Active, not recruiting |
: Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients With Pancreatic Cancer :
|
Suspended |
: Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery :
|
Completed |
: Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine Hydrochloride :
|
Completed |
: Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas :
|
Completed |
: Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer :
|
Active, not recruiting |
: Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer :
|
Recruiting |
: High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery :
: |